Aureus Asset Management’s Biogen BIIB Stock Holding History

Aureus Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-625	Closed	-$207K	–	135
2014 Q3	$207K	Buy	+625	New	+$206K	0.05%	125

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Aureus Asset Management's BIIB Position: Q4 2014 in Review

Aureus Asset Management sold out of Biogen (BIIB) in Q4 2014, closing a stake of 625 shares — an estimated $207K sold.

Aureus Asset Management first reported a position in BIIB in Q3 2014 and held it in 1 quarter. The position peaked at $207K in Q3 2014. 885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

Aureus Asset Management reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
Aureus Asset Management sold 625 Biogen shares in Q4 2014, an estimated $207K.
Aureus Asset Management first reported a position in Biogen in Q3 2014 and held it in 1 quarter.
Aureus Asset Management's Biogen position peaked at $207K in Q3 2014.
885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Aureus Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.